plerixafor has been researched along with Myocardial Infarction in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| He, Y; Ji, Y; Yao, J | 1 |
| Magga, J; Mustonen, E; Renko, O; Ruskoaho, H; Rysä, J; Serpi, R; Tolonen, AM | 1 |
| Huang, T; Ji, W; Jiang, T; Li, Y; Liu, H; Luo, T; Luo, Y; Zhang, L; Zhao, X; Zhou, X | 1 |
| Haase, T; Kamann, S; Krost, A; Langwieser, N; Peter, J; Rüder, C; Zohlnhöfer, D | 1 |
| Abadeh, A; Advani, A; Advani, SL; Connelly, KA; Desjardins, JF; Gilbert, RE; Kabir, G; Mitchell, M; Thai, K; Zhang, Y | 1 |
| Clarke, T; Hagiwara, N; Hamada, H; Ito, A; Iwakura, A; Jujo, K; Klyachko, E; Kobayashi, K; Losordo, DW; Misener, S; Roncalli, J; Sekiguchi, H; Tanaka, T; Thorne, T; Tongers, J; Tsurumi, Y | 1 |
| Bolli, R; Chen, N; Dai, S; Guo, S; Kingery, J; Li, C; Mu, J; Prabhu, SD; Rokosh, G; Yuan, F | 1 |
| Chen, Y; Han, H; Hong, D; Qiao, H; Tong, Y; Wu, Y; Xu, W; Yang, J; Zhou, C | 1 |
| Ii, M; Jujo, K; Kamide, C; Klyachko, E; Losordo, DW; Misener, S; Renault, MA; Roncalli, J; Tanaka, T; Thorne, T; Tongers, J | 1 |
| Assmann, G; Brunner, S; Fischer, R; Franz, WM; Gröbner, M; Hacker, M; Huber, B; Krieg, L; Mueller-Hoecker, J; Rischpler, C; Theiss, HD; Vallaster, M; Vanchev, Y; Wollenweber, T; Zaruba, MM | 1 |
| Cai, A; Dong, Y; Feng, Y; Huang, Y; Mai, W; Qiu, R; Rao, S; Yu, D; Zheng, D; Zhou, Y | 1 |
| Asahi, M; Clarke, T; Hagiwara, N; Ii, M; Ito, A; Jujo, K; Kamide, C; Klyachko, E; Losordo, DW; Misener, S; Qin, G; Renault, MA; Roncalli, J; Sekiguchi, H; Tanaka, T; Thorne, T; Tongers, J; Tsurumi, Y | 1 |
| Abbott, JD; Giordano, FJ; Hickey, R; Huang, Y; Krause, DS; Liu, D | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Minatoguchi, S; Misao, Y; Ohno, T; Onogi, H; Takahashi, T; Takemura, G | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Kobayashi, H; Minatoguchi, S; Misao, Y; Ohno, T; Onogi, H; Takemura, G; Ushikoshi, H | 1 |
| Calderone, A; Clement, R; El-Helou, V; Gillis, MA; Gosselin, H; Proulx, C; Villeneuve, L | 1 |
| Hatake, K; Hongo, M; Ikeda, U; Ise, H; Izawa, A; Morimoto, H; Motoyoshi, K; Shiba, Y; Takahashi, M | 1 |
17 other study(ies) available for plerixafor and Myocardial Infarction
| Article | Year |
|---|---|
Extracellular ubiquitin protects cardiomyocytes during ischemia/hypoxia by inhibiting mitochondrial apoptosis pathway through CXCR4.
Topics: Animals; Apoptosis; Autophagy; Benzylamines; Cell Survival; Cyclams; Down-Regulation; Extracellular Space; Heterocyclic Compounds; Hypoxia; Ischemia; Mitochondria; Myocardial Infarction; Myocytes, Cardiac; Rats; Receptors, CXCR4; Ubiquitin; Up-Regulation | 2020 |
SDF1 gradient associates with the distribution of c-Kit+ cardiac cells in the heart.
Topics: Adult Stem Cells; Animals; Benzylamines; Cell Movement; Cells, Cultured; Chemokine CXCL12; Cyclams; Disease Models, Animal; Gene Expression Regulation; Heart Atria; Heart Ventricles; Heterocyclic Compounds; Male; Myocardial Infarction; Myocardium; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Regeneration | 2018 |
Short-term intermittent administration of CXCR4 antagonist AMD3100 facilitates myocardial repair in experimental myocardial infarction.
Topics: Animals; Base Sequence; Benzylamines; Cyclams; DNA Primers; Heterocyclic Compounds; Male; Myocardial Infarction; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.
Topics: Animals; Benzylamines; Cyclams; Disease Models, Animal; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Heart; Heterocyclic Compounds; Male; Mice; Myocardial Infarction | 2014 |
Dipeptidyl peptidase-4 inhibition improves cardiac function in experimental myocardial infarction: Role of stromal cell-derived factor-1α.
Topics: Adamantane; Animals; Benzylamines; Cardiac Catheterization; Chemokine CXCL12; Cyclams; Diabetes Mellitus, Experimental; Dipeptides; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Echocardiography; Glucagon-Like Peptide-1 Receptor; Heterocyclic Compounds; Hypoglycemic Agents; Liraglutide; Male; Myocardial Infarction; Rats; Rats, Inbred F344 | 2016 |
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
Topics: Animals; Base Sequence; Benzylamines; Blood Cell Count; Bone Marrow Transplantation; Capillaries; Cyclams; DNA Primers; Endothelial Cells; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myocardial Infarction; Neovascularization, Physiologic; Receptors, CXCR4; Vascular Endothelial Growth Factor A | 2010 |
Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction.
Topics: Animals; Benzylamines; Blotting, Western; Chemokine CXCL12; Cyclams; Cyclin D1; Echocardiography; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Phosphorylation; Protein Binding; Receptors, CXCR4 | 2010 |
Tanshinone IIA increases recruitment of bone marrow mesenchymal stem cells to infarct region via up-regulating stromal cell-derived factor-1/CXC chemokine receptor 4 axis in a myocardial ischemia model.
Topics: Abietanes; Animals; Benzylamines; Bone Marrow Cells; Cell Movement; Chemokine CXCL12; Cyclams; Disease Models, Animal; Drugs, Chinese Herbal; Female; Heterocyclic Compounds; Male; Mesenchymal Stem Cells; Myocardial Infarction; Myocardial Ischemia; Myocardium; Phytotherapy; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Salvia miltiorrhiza; Stem Cell Transplantation; Up-Regulation | 2011 |
Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization.
Topics: Animals; Benzylamines; Cell Movement; Cyclams; Disease Models, Animal; Gene Transfer Techniques; Genetic Therapy; Hedgehog Proteins; Heterocyclic Compounds; Humans; Injections, Intralesional; Injections, Subcutaneous; Mice; Mice, Knockout; Myocardial Infarction; Neovascularization, Physiologic; Random Allocation; Sensitivity and Specificity; Stem Cells; Survival Rate; Treatment Outcome; Ventricular Remodeling | 2011 |
Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis.
Topics: Animals; Antigens, CD34; Benzylamines; Chemokine CXCL12; Cyclams; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; Heart Function Tests; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Leukocyte Common Antigens; Mice; Models, Biological; Myocardial Infarction; Neovascularization, Physiologic; Oligopeptides; Perfusion; Proto-Oncogene Proteins c-kit; Receptors, CXCR4; Stem Cell Transplantation; Survival Analysis | 2011 |
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Atorvastatin; Benzylamines; Chemokine CXCL12; Coronary Vessels; Cyclams; Heptanoic Acids; Heterocyclic Compounds; Ligation; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; STAT3 Transcription Factor; Up-Regulation | 2012 |
CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.
Topics: Animals; Benzylamines; Bone Marrow Transplantation; Cardiotonic Agents; Cyclams; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; Receptors, CXCR4; Recovery of Function; Signal Transduction | 2013 |
Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.
Topics: Animals; Benzylamines; Bone Marrow Cells; Bone Marrow Transplantation; Cell Lineage; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Cyclams; Female; Gene Expression Profiling; Gene Expression Regulation; Genetic Therapy; Heterocyclic Compounds; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 9; Mice; Mice, Inbred NOD; Mice, SCID; Myocardial Infarction; Myocardium; Receptors, CXCR4; Recombinant Fusion Proteins; Stem Cell Transplantation; Stem Cells; Transduction, Genetic; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2004 |
Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF.
Topics: Animals; Benzylamines; Bone Marrow Cells; Chemokine CXCL12; Chemokines, CXC; Cyclams; Granulocyte Colony-Stimulating Factor; Hemodynamics; Heterocyclic Compounds; Leukocyte Count; Male; Matrix Metalloproteinase 1; Myocardial Infarction; Rabbits; Receptors, CXCR4; STAT3 Transcription Factor; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |
Modification of post-myocardial infarction granulocyte-colony stimulating factor therapy with myelo-suppressives.
Topics: Animals; Apoptosis; Benzylamines; Blood Cell Count; Chemokine CXCL12; Chemokines, CXC; Cyclams; Cyclophosphamide; Drug Therapy, Combination; Echocardiography; Endothelial Cells; Fluorouracil; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Immunosuppressive Agents; Male; Myocardial Infarction; Myocytes, Cardiac; Rabbits; Receptors, CXCR4; Ventricular Remodeling | 2007 |
Antagonism of stromal cell-derived factor-1alpha reduces infarct size and improves ventricular function after myocardial infarction.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.
Topics: Animals; Apoptosis; Benzylamines; Cell Differentiation; Cells, Cultured; Chemokine CXCL12; Collagen; Cyclams; Cytokines; Echocardiography; Endothelial Cells; Granulocyte Colony-Stimulating Factor; Heterocyclic Compounds; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Receptor, Macrophage Colony-Stimulating Factor; Receptors, CXCR4; Receptors, Granulocyte Colony-Stimulating Factor; Transforming Growth Factor beta1; Ventricular Remodeling | 2007 |